University of Texas's MD Anderson Cancer: Classifying EGFR Mutations by Structure Offers Better Way to Match Non-Small Cell Lung Cancer Patients to Treatments
September 16, 2021
September 16, 2021
HOUSTON, Texas, Sept. 16 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 15, 2021:
* * *
Study identifies four novel subgroups that predict drug response
* * *
Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provides an accurate framework to match patients wi . . .
* * *
Study identifies four novel subgroups that predict drug response
* * *
Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provides an accurate framework to match patients wi . . .